| Revenue | SEK 2,8M | +6% |
| EBITDA | SEK 2,4M | +19% |
| Net profit | SEK -2K | — |
| Total assets | SEK 29,4M | +0% |
| Equity | SEK 9,8M | +0% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 170 | 2 144 | 2 280 | 2 602 | 2 762 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 808 | 1 796 | 1 875 | 2 049 | 2 435 |
| Depreciation & amort. | −196 | −196 | −210 | −251 | −252 |
| EBIT | 1 612 | 1 600 | 1 665 | 1 798 | 2 183 |
| Net financials | 38 | 26 | 50 | −22 | −5 |
| Profit before tax | 83 | 26 | 50 | 0 | −2 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 83 | 26 | 50 | 0 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 29 784 | 31 619 | 32 116 | 29 443 | 29 433 |
| Equity | 9 704 | 9 730 | 9 780 | 9 780 | 9 778 |
| Long-term debt | 19 140 | 19 140 | 21 140 | 19 140 | 19 140 |
| Short-term debt | 940 | 2 750 | 1 196 | 375 | 314 |
| Total debt | 20 080 | 21 890 | 22 336 | 19 515 | 19 454 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
EO Chief Auditor | Chief Auditor | 2020 – 2022 |
SJ Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Wall | Chief Auditor | 0 companies |
| Erik John-David Larsson | Chief Auditor | 0 companies |
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Per-Henrik Roger Karlsson | Deputy Board Member | 0 companies |
| Mikael Ulf Robert Nicander | Board of Directors | 0 companies |
| Jan Erik Alexander Ranje | Board of Directors | 0 companies |